Details for 2015715172
Up to date per 03.04.2026
Actions
Details for 2015715172
Granted/Registered
European Patent
18.01.2017 A
02.03.2022 B1
11.03.2014
GB
201404301
26.11.2014
GB
201421019
C07K 7/62 20060101AFI20150921BHEP
Owner
Spero Therapeutics, Inc.675 Massachusetts Avenue 14th Floor Cambridge, Massachusetts 02139US
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
BROWN, Pamelac/o Cantab Anti-Infectives Limited 4th Floor Reading Bridge House George Street Reading Berkshire RG1 9LSGB
DAWSON, Michaelc/o Cantab Anti-Infectives Limited 4th Floor Reading Bridge House George Street Reading Berkshire RG1 9LSGB
SIMONOVIC, Monac/o Cantab Anti-Infectives Limited 4th Floor Reading Bridge House George Street Reading Berkshire RG1 9LSGB
BOAKES, Stevenc/o Cantab Anti-Infectives Limited 4th Floor Reading Bridge House George Street Reading Berkshire RG1 9LSGB
DUPERCHY, Estherc/o Cantab Anti-Infectives Limited 4th Floor Reading Bridge House George Street Reading Berkshire RG1 9LSGB
STANWAY, Steven Jamesc/o Selcia Limited Fyfield Business and Research Park Fyfield Road Ongar Essex CM5 0GSGB
WILSON, Antoinettec/o Selcia Limited Fyfield Business and Research Park Fyfield Road Ongar Essex CM5 0GSGB
MOSS, Stephen Frederickc/o Selcia Limited Fyfield Business and Research Park Fyfield Road Ongar Essex CM5 0GSGB
Information about Fees